Suggestions
Laura Hagan
Executive Director, Chief Medical Office at Novartis
Professional Background
Laura Hagan is a highly accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors, particularly in portfolio management and strategic operations. Currently serving as the Executive Director and Chief Medical Officer at Novartis, Laura has demonstrated her remarkable ability to navigate complex project landscapes and drive cross-functional teams toward achieving strategic objectives. Her strong leadership skills and deep expertise in oncology research have made her an invaluable asset in every organization she has been part of.
Before her role at Novartis, Laura served as the Director of Strategic & Operational Portfolio Management at Bristol-Myers Squibb, where she honed her abilities in strategic planning, resource allocation, and operational efficiency. This role allowed her to manage high-stakes projects and lead initiatives that aimed to enhance the company’s product pipeline. Additionally, she worked as the Associate Director of Portfolio Management & Strategic Outsourcing at Schering-Plough Research Institute. Laura’s insights and strategic thinking were instrumental in optimizing the company’s research operations.
Her career began at Schering-Plough Research Institute, where she held a pivotal position as Associate Director of Oncology Research & Operations Management. This initial role solidified her passion for research and development in the field of oncology, and her contributions greatly advanced the institute’s capabilities in delivering innovative therapies. Through her various career roles, Laura has built a strong reputation for her collaborative approach and her commitment to delivering excellence in everything she undertakes.
Education and Achievements
Laura Hagan's academic foundation is robust and diverse, with a notable educational background that supports her professional endeavors. She holds a Master’s Degree in Zoology/Animal Biology from Rutgers, The State University of New Jersey-Newark. This advanced education has equipped her with an intricate understanding of animal biology, an essential element in the pharmacological development process.
Prior to her master’s, Laura earned a Bachelor’s Degree in Chemistry from the University of Arizona. This degree provided her with a solid grounding in the principles of chemistry and its applications, which are critical in the drug development landscape, particularly within the pharmaceutical sciences.
Achievements
Throughout her impressive career, Laura Hagan has achieved significant milestones that highlight her expertise and dedication in her field. Her leadership at Novartis has led to the successful advancement of multiple oncology programs, showcasing her depth of knowledge in cancer research and product development. Furthermore, her previous positions at renowned companies such as Bristol-Myers Squibb and Schering-Plough underscore her capacity to contribute strategically and operationally to high-profile projects.
Laura’s ability to engage with scientific communities and translate complex scientific information into actionable strategies has made her a respected figure among her peers. She frequently collaborates with various stakeholders and is known for her commitment to advancing health care solutions through innovative research and operational management.
In summary, Laura Hagan’s professional trajectory is marked by her steadfast commitment to excellence in the pharmaceutical industry. Her educational background, combined with her extensive experience in oncology and strategic portfolio management, positions her as a leader in shaping the future of medical research and drug development. Laura continues to inspire those around her with her passion for science and dedication to improving patient outcomes.
